Who Is Shaping the Future of RNA-Targeted Drug Discovery? Industry Leaders to Gather in Boston This November
The 9th Annual RNA-Targeted Drug Discovery & Development Summit will unite the scientists, drug developers, and industry leaders advancing RNA-targeted small molecules from early discovery through clinical development. Taking place November 10-12 in Boston, the meeting brings together experts across pharma, biotech, and academia to discuss the latest scientific and translational breakthroughs in the field.
For Large Pharma Leaders
Companies including AstraZeneca, Sanofi, Pfizer, Novartis, Eli Lilly, Astellas, Chugai, and Daiichi Sankyo attend to evaluate RNA-targeted small molecules as an emerging therapeutic modality and benchmark the latest advances in target selection, medicinal chemistry, and translational development.
For Biotech Decision-Makers & Drug Developers
Leaders from Remix Therapeutics, PTC Therapeutics, ReviR Therapeutics, Arrakis Therapeutics, Ribonaut Therapeutics, Dewpoint Therapeutics, Atomic AI, Syrna Therapeutics, and more will share how they are advancing pipelines, overcoming discovery challenges, and translating RNA biology into therapeutic programmes.
For Discovery & Translational Scientists
Researchers across RNA Biology, Medicinal Chemistry, Drug Discovery, Screening, Structural Biology, Computational Biology, and Translational Sciences will gain practical insights into ligandable target identification, AI-enabled discovery, direct RNA binding, splice modulation, and target engagement strategies.
For Academic & Research Pioneers
Leading researchers from institutions including UNC Chapel Hill, University of Toronto, University of Colorado Boulder, and University of Wisconsin-Madison will showcase new findings in RNA structure, biology, druggability, and small molecule development.
As clinical momentum continues to build across the RNA-targeted therapeutics landscape, the summit offers a unique opportunity to connect with the organizations and individuals shaping the future of the field.
Download the official event guide to explore the full agenda, speaker faculty and networking opportunities.
Register before September 18 to save up to $520 on your place and join the industry’s leading forum dedicated to RNA-targeted small molecule discovery and development.